Funded Tech Companies

NuProbe

Wondering who backed NuProbe? AstraZeneca, Panlin Capital and Haoreng Capital joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

NuProbe brings together cutting-edge innovations in molecular engineering with leading scientific expertise and management to take on one of the world's greatest challenges -- non-invasive early detection of rare genetic variants in patients.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/3/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Yingshuang Chai

        

Co-Founder

Victor Shi

        

Co-Founder

Peng Yin

        

Co-Founder

David Zhang

        

VP - Bus. Development

Nicolas de Loubresse

        

VP - Manufacturing

Hu Ouyang

        

VP - Marketing

Song Gao

        

VP - R & D

Yundi Chen

        

VP - R & D

Junfeng Luo

        

VP - Sales

Yu Zhou

        

Company Investors

• AstraZeneca
• Panlin Capital
• Haoreng Capital
• Yonghua Capital
• Deguan Capital
• Pappas Ventures
• BioTrack Capital
• Sequoia Capital (Neil Shen)
• CR-CP Life Science Fund
• Ruomu Capital
• Serica Partners (Victor Shi)
• Juming Capital
• Taifu Capital
• Tuobang Capital
• WuXi AppTec

Browse more funded tech companies:

NuPotential | Nuqlea

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary